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Gakkaizasshi in Japanese (The Journal of the Japanese
Respiratory Society), is the first official journal of the Japa-
nese Respiratory Society (JRS) in English. It was launched as a
quarterly journal in March 2012. It reports original manu-
scripts on investigations of any respiratory diseases from
bench to bedside. Our journal is particularly interested in
publishing articles that focus on the diversity of disease
manifestations based on genetic and/or environmental dif-
ferences between the East and West. The journal enthusias-
tically welcomes contributions not only from the Japanese
members of our Society but also from non-members hailing
from neighboring countries in Asia.
In recent years, the progress of medical science and
technology has been astounding, and we are fortunate to
get access to such progress wherever we are on the globe.
Thanks to the internet, we can easily obtain novel informa-
tion in any field of medicine, and the huge amount of
available new information may be overwhelming even if
limited to one’s field of expertise. We often find ourselves
easily convinced and persuaded by articles published in
worldwide prestigious journals such as The New England
Journal of Medicine and The Lancet. However, being Japanese,
it is not uncommon for us to feel a certain uneasiness when
we encounter such highly influential articles. This is because
a majority of such articles come from Western societies.
‘‘Phenotyping’’ is a fashionable term used to describe the
variable forms and clinical manifestations of common dis-
eases such as asthma and COPD. This is because we tend to
feel that precise ‘‘phenotyping’’ may lead to personalized
medicine in the future. Large-scaled, multi-center, rando-
mized clinical trials provide us high-quality evidence; how-
ever, such data do not always give us the best answer on an
individual basis. In COPD, for instance, although the concept
of the BODE index is well accepted worldwide, direct applica-
tion of BMI scores to Asian patients would not be feasible.
This is because of the tremendous five-point difference in the
average BMI score between Eastern and Western populations
(21–22 vs. 26–27). Such marked differences in clinical mani-
festations may also exist in comorbidities and causes of
deaths in patients with COPD.As respiratory physicians, we see patients with a variety of
lung diseases, and we know that remarkable phenotypic
differences may also exist in other major lung diseases. In
our society, acute exacerbation of idiopathic pulmonary
fibrosis has drawn attention for many years as a major
threatening event and even as a cause of death, but it has
been only recently recognized in Western societies. In
patients with severe asthma, serious concerns surround
elderly individuals, many of whom are smokers with or
without COPD. In lung cancer, it is well known that the EGFR
driver mutation is much more prevalent in non-smoking
Asian women compared to their Western counterparts,
which certainly accounts for a favorable response to a
selective tyrosine kinase inhibitor in the former ethnic group.
These clinical characteristics of the Japanese (and potentially
other Asians as well) may or may not be linked with genetic
differences. In some cases, environmental factors may influ-
ence phenotypic expressions. Evidence for this can be seen in
the dramatic changes in the phenotype of COPD for the last
three decades. In the past, many patients would complain of
voluminous sputum and were hospitalized because of
exacerbation, particularly in the winter; however, we rarely
see patients like these with bronchial hypersecretion nowa-
days. Far more dramatic is the case of diffuse panbronchio-
litis (DPB), which used to be found exclusively in East Asia.
Nowadays, it is rarely seen in Japan.
Considering such remarkable phenotypic differences
between the East and West and/or between Japan and other
parts of the world, it would indeed be an excellent opportu-
nity and an exciting challenge for the JRS to have our own
journal, ‘‘Respiratory Investigation’’, in English. I hope that by
studying the mechanisms behind such phenotypic differ-
ences we may help establish and further develop persona-
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